NOVEL INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
申请人:CHU Daniel
公开号:US20090062268A1
公开(公告)日:2009-03-05
A compound having the structure set forth in Formula (I):
wherein the variables Y, R
1
, R
2
, R
3
, R
4
and R
5
are as defined herein. Compounds described herein are inhibitors of poly(ADP-ribose)polymerase activity. Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of such compounds and pharmaceutical compositions to treat diseases, disorders and conditions that are ameliorated by the inhibition of PARP activity.
SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS
申请人:Giranda Vincent L.
公开号:US20070259937A1
公开(公告)日:2007-11-08
The present invention relates to 1H-benzimidazole-4-carboxamides of formula (I),
their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase for the preparation of drugs.
Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
申请人:Bayer CropScience AG
公开号:EP2561759A1
公开(公告)日:2013-02-27
Use of fluoroalkyl-substituted 2-amidobenzimidazoles of the formula (I), or agriculturally acceptable salts thereof,
for the treatment of plants for inducing growth regulating responses on plants, on seeds from which they grow or on the locus in which they grow in their normal habitat and in the absence of extraordinary environmental conditions and which result in superior growth of these treated plants, certain parts of these plants or, more generally, crop yield.
Use of fluoroalkyl-substituted 2-amidobenzimidazoles of the formula (I), or salts thereof,
for enhancing stress tolerance in plants to abiotic stress, especially for strengthening plant growth and/or for increasing plant yield, and selected processes for preparing such fluoroalkyl-substituted 2-amidobenzimidazoles of the formula (I).
1H-BENZIMIDAZOLE-4-CARBOXAMIDES SUBSTITUTED WITH PHENYL AT THE 2-POSITION ARE POTENT PARP INHIBITORS
申请人:Penning D. Thomas
公开号:US20070179136A1
公开(公告)日:2007-08-02
Compound having formula (I)
inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds having formula (I), methods of treatment comprising compounds having formula (I), and methods of inhibiting the PARP enzyme comprising compounds having formula (I).